Clinical characteristics of pyrazinamide-associated hepatotoxicity in patients at a hospital in Lima, Peru.
In conclusion, pyrazinamide-associated DILI required prolonged hospital stay, presented jaundice in little more than a third of the cases, and radiologically, the hepatocellular pattern predominated.
PMID: 33295555 [PubMed - in process]
Source: Revista Peruana de Medicina de Experimental y Salud Publica - Category: International Medicine & Public Health Tags: Rev Peru Med Exp Salud Publica Source Type: research
More News: International Medicine & Public Health | Jaundice | Liver | Peru Health | Tuberculosis | Urology & Nephrology